Arcus Biosciences, Inc.
RCUS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$135,000 | $0 | -$112,000 | -$94,000 |
| Dep. & Amort. | $2,000 | $2,000 | $3,000 | $3,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14,000 | $0 | $16,000 | $17,000 |
| Change in WC | $21,000 | -$148,000 | -$37,000 | -$23,000 |
| Other Non-Cash | $1,000 | $13,000 | -$2,000 | -$3,000 |
| Operating Cash Flow | -$97,000 | -$133,000 | -$132,000 | -$100,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$1,000 | -$1,000 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$165,000 | -$161,000 | -$353,000 | -$172,000 |
| Inv. Sales/Matur. | $244,000 | $298,000 | $386,000 | $224,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $79,000 | $137,000 | $32,000 | $51,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $49,000 | $0 | $0 |
| Stock Issued | $8,000 | $3,000 | $142,000 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$2,000 |
| Financing Cash Flow | $8,000 | $52,000 | $142,000 | -$2,000 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,000 | $56,000 | $42,000 | -$51,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251,000 | $192,000 | $153,000 | $204,000 |
| End Cash | $241,000 | $248,000 | $195,000 | $153,000 |
| Free Cash Flow | -$97,000 | -$133,000 | -$133,000 | -$101,000 |